We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.74B
AUM Growth
+$109M
Cap. Flow
-$39.8M
Cap. Flow %
-1.07%
Top 10 Hldgs %
14.14%
Holding
1,395
New
97
Increased
557
Reduced
530
Closed
105

Sector Composition

Rank Sector Weight
1 Healthcare 13.61%
2 Financials 11.8%
3 Technology 10.96%
4 Industrials 9.65%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNLA icon
451
Janus Henderson Short Duration Income ETF
VNLA
$3.32B
$1.57M 0.04%
+31,286
New +$1.57M
IPGP icon
452
IPG Photonics
IPGP
$3.61B
$1.56M 0.04%
+8,459
New +$1.41M
WYNN icon
453
Wynn Resorts
WYNN
$10.3B
$1.56M 0.04%
10,480
-17,283
-62% -$2.36M
MTRN icon
454
Materion
MTRN
$4.39B
$1.56M 0.04%
36,150
-150
-0.4% -$5.75K
SPHD icon
455
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.34B
$1.56M 0.04%
38,035
-2,902
-7% -$117K
RF icon
456
Regions Financial
RF
$26.4B
$1.55M 0.04%
101,984
+5,540
+6% +$79.7K
SYY icon
457
Sysco
SYY
$40.8B
$1.55M 0.04%
28,813
-3,668
-11% -$191K
ECL icon
458
Ecolab
ECL
$78.1B
$1.54M 0.04%
12,014
+591
+5% +$77.7K
PPLI
459
People Inc
PPLI
$3.09B
$1.54M 0.04%
73,434
-10,732
-13% -$208K
LRCX icon
460
Lam Research
LRCX
$367B
$1.54M 0.04%
83,410
-7,310
-8% -$119K
MINT icon
461
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$1.54M 0.04%
15,148
+8,702
+135% +$885K
SRPT icon
462
Sarepta Therapeutics
SRPT
$1.57B
$1.52M 0.04%
33,592
+11,639
+53% +$465K
FXO icon
463
First Trust Financials AlphaDEX Fund
FXO
$1.13B
$1.52M 0.04%
51,229
+2,802
+6% +$81.3K
NXPI icon
464
NXP Semiconductors
NXPI
$57.8B
$1.51M 0.04%
13,390
+9,767
+270% +$1.09M
AABA
465
DELISTED
Altaba Inc
AABA
$1.51M 0.04%
22,814
+1,124
+5% +$69K
CLX icon
466
Clorox
CLX
$11.6B
$1.5M 0.04%
11,398
+304
+3% +$40.8K
EPAC icon
467
Enerpac Tool Group
EPAC
$1.83B
$1.49M 0.04%
58,357
+1,269
+2% +$31K
IPAY icon
468
Amplify Mobile Payments ETF
IPAY
$170M
$1.49M 0.04%
+45,523
New +$1.43M
BIVV
469
DELISTED
Bioverativ Inc. Common Stock
BIVV
$1.49M 0.04%
26,081
-1,206
-4% -$70.6K
DVY icon
470
iShares Select Dividend ETF
DVY
$23.5B
$1.49M 0.04%
15,878
-479
-3% -$44.3K
BNY
471
Bank of New York Mellon
BNY
$106B
$1.48M 0.04%
27,957
+646
+2% +$33.9K
HSY icon
472
Hershey
HSY
$35.5B
$1.48M 0.04%
13,571
-854
-6% -$91K
MYGN icon
473
Myriad Genetics
MYGN
$270M
$1.48M 0.04%
40,850
-250
-0.6% -$7.13K
GPC icon
474
Genuine Parts
GPC
$17.1B
$1.47M 0.04%
15,402
+4,626
+43% +$394K
XL
475
DELISTED
XL Group Ltd.
XL
$1.47M 0.04%
37,352
+5,354
+17% +$229K

Similar funds

Oppenheimer & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Oppenheimer & Co held 1,395 positions worth $3.74B, up 3% from $3.63B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2017 filing shows 97 new, 557 increased, 530 reduced and 105 closed positions. Its largest new stake was Jacobs Solutions: 99,458 shares worth $4.79M. The largest sale was Du Pont De Nemours E I, an estimated $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q3 2017 buy was Jacobs Solutions: 99,458 shares worth $4.79M.
  • Oppenheimer & Co added most to DuPont de Nemours in Q3 2017, an estimated $13.6M increase.
  • Oppenheimer & Co's biggest Q3 2017 reduction was Amgen, cutting an estimated $5.53M.
  • Oppenheimer & Co fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $13.5M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.74B portfolio in Q3 2017.
  • Oppenheimer & Co opened 97 new positions and closed 105 in Q3 2017.
  • Oppenheimer & Co's portfolio value rose 3% quarter-over-quarter to $3.74B.

Based on Oppenheimer & Co's 13F filing for Q3 2017, filed 9 Nov 2017.